sium coupled with results from different cross-linking assays suggests ␣-hydroxytropolones as interfacial inhibitors. We propose that ␣-hydroxytropolones chelate the divalent metal (Mg 2ϩ or Mn 2ϩ ) in the enzyme active site. The most active compound against HIV-1 integrase in biochemical assays [2,4,6-cycloheptatrien-1-one, 2,7-dihydroxy-4-isopropyl (NSC 18806) IC 50 ϭ 4.8 Ϯ 2.5 M] exhibits weak cytoprotective activity against HIV-1 IIIB in a cell-based assay. ␣-Hydroxytropolones represent a new family of inhibitors for the development of novel drugs against HIV infection.
The screening and investigation of novel drugs against human immunodeficiency virus (HIV) remain critical because of the ongoing AIDS epidemics and because of the fast emergence of virus variants resistant to present antiviral therapy (Kellerman et al., 2005) . The replication steps of HIV, a member of the retrovirus family, are well known and can therefore be targeted rationally (for general review, see De Clercq, 2005) . After HIV binding to the host cell, viral single-stranded RNA genomes are released into the cell and serve as templates for the virus-encoded reverse transcriptase to synthesize double-stranded DNA copies bearing the long terminal repeats (LTRs) at both ends (Turner and Summers, 1999) . The viral linear DNA is integrated into the host genome in a reaction catalyzed by the viral enzyme integrase (IN). Integration is essential for viral replication because integrated viral DNA (provirus) serves as a template for the synthesis of new viruses after processing by the host cell transcription-translation machines (Brown, 1990; Fesen et al., 1993; Asante-Appiah and Skalka, 1997; Van Maele and Debyser, 2005) .
Antiviral therapy currently uses a combination of reverse transcriptase and HIV protease inhibitors. Inhibitors of virus fusion to the host cells have recently been developed (Barbaro et al., 2005; De Clercq, 2005) . Because HIV integrase is crucial for virus replication, the search for integrase inhibitors has been ongoing (Fesen et al., 1993; Hazuda et al., 2000; Debyser et al., 2002; Deprez et al., 2004; Johnson et al., 2004; . Integrase inserts the proviral DNA into host chromosomes in two steps: 3Ј processing (3Ј-P) and strand transfer (ST). 3Ј-P is an endonucleolytic cleavage reaction removing the 3Ј ends of the viral LTR DNA (generally a dinucleotide pGpT for HIV-1) immediately 3Ј from the conserved sequence (CA for HIV-1) (Fig. 1A) . ST is the insertion of the processed 3Ј ends of the viral DNA into the cell genome (Asante-Appiah and Skalka, 1997). The HIV-1 integrase catalytic site contains three essential amino acids: Asp64, Asp116, and Glu152 (D,D-35 E-motif) that coordinate at least one and probably two divalent cations (Mg 2ϩ or Mn 2ϩ ) between the enzyme and its DNA substrates (Engelman and Craigie, 1992; Chiu and Davies, 2004) .
The ST inhibitors 5-chloroindolyltetrazolylpropenone and L-731,988 have been proposed to chelate the divalent metal cations (Mg 2ϩ or Mn 2ϩ ) in the enzyme active site (Grobler et al., 2002; Marchand et al., 2003; . 5-Chloroindolyltetrazolylpropenone has been cocrystallized in the catalytic domain of HIV integrase and shown to bind in the DDE motif (Goldgur et al., 1999) . The diketo acid derivative L-731,988 was shown to block binding of target DNA in the integrase active site . The selective inhibition of the strand transfer reaction by diketo acids has been proposed to be due to their interfacial inhibition on preformed integrase-viral DNA complexes .
We previously reported one derivative (NSC 624404) containing the characteristic seven-membered tropolone ring as novel inhibitor of HIV-1 integrase in a four-point pharmacophore analysis of the National Cancer Institute drug database (Neamati et al., 1997) . While screening the National Cancer Institute chemical library for HIV-1 integrase inhibitors, we recently found additional positive hits with tropolone derivatives. We report here the structure-activity relationship of tropolones available in the National Cancer Institute compound repository on HIV integrase activities. Tropolone derivatives are present in cupressaceous trees from genus Thuja and are probably responsible for resistance of fungal and insect attack on the heartwood (Baya et al., 2001; Diouf et al., 2002; Lim et al., 2005) . Our experiments demonstrate the ability of the monomer 7-hydroxytropolones (␣-hydroxytropolones) to preferentially inhibit the ST reaction by interfering with the enzyme catalytic site. ␣-Hydroxytropolone derivatives are new lead inhibitors for HIV-1 integrase.
Materials and Methods
Compounds. All drugs were obtained from the National Cancer Institute chemical repository from the Developmental Therapeutics Program (National Institutes of Health, Bethesda, MD). Compounds were dissolved in 100% DMSO. Stock solutions (10 mM) were stored at Ϫ20°C.
Recombinant HIV Integrase and Oligonucleotide Substrates. Expression and purification of the recombinant HIV-1 integrase in Escherichia coli were performed according to Leh et al. (2000) and Marchand et al. (2001) with addition of 10% glycerol to all buffers. The preparation of the Q148C/SSS-mutant integrase is described in Johnson et al. (2006) . The oligonucleotide substrates, except those used for the disulfide cross-linking (Fig. 5A) (He and Verdine, 2002) .
Integrase Catalytic Assays. Reactions were performed in 10 l with 300 nM recombinant IN, 20 nM 5Ј end 32 P-labeled oligonucleotide substrates, and inhibitors at the indicated concentrations. We included 10% DMSO in controls. Reactions were incubated for 40 min at 37°C in a buffer containing a final concentration of 25 mM MOPS, pH 7.2, 25 mM NaCl, 14.3 mM ␤-mercaptoethanol, and 7.5 mM divalent cations (MgCl 2 or MnCl 2 as indicated). Reactions were stopped by addition of 20 l of loading dye (10 mM EDTA, 98% deionized formamide, 0.025% xylene cyanol, and 0.025% bromphenol blue). Reactions were heated at 95°C for 1 min before electrophoresis in 20% polyacrylamide-7 M urea gels. Gels were dried, and reaction products were visualized and quantitated with a PhosphorImager (GE Healthcare, Little Chalfont, Buckinghamshire, UK). Densitometric analyses were performed using ImageQuant from the Molecular Dynamics software. The concentrations at which enzyme activity was reduced by 50% (IC 50 ) was determined using Prism software (GraphPad Software Inc., San Diego, CA) for nonlinear regression to fit dose-response data to logistic curve models.
Integrase Binding to HIV DNA Using the Disulfide-CrossLinking Assay. The disulfide cross-linking assay was described in detail previously (Johnson et al., 2006) . In brief, 10 M recombinant Q148C/SSS-mutant integrase was incubated with 10 M DNA substrate ( Fig. 5A ) containing tethered thiols in the presence of 20 mM Tris, pH 7.4, 10% glycerol, and 7.5 mM divalent cations (MgCl 2 or MnCl 2 as indicated) for 20 min at 37°C. Reactions were stopped by the addition of 20 mM methylmethanethiosulfonate (capping reagent). Nonreducing gel loading buffer (100 mM Tris-HCl, pH 6.8, 4% SDS, 0.2% bromphenol blue, and 20% glycerol) was added, and samples were heated at 95°C before loading onto 16% Tricine gels (Invitrogen, Carlsbad, CA). Gels were stained with Microwave Blue according to manufacturer's recommendations (Protiga, Frederick, MD).
Otherwise, for dose-response experiments, 500 nM integrase was incubated with NSC 18806 as shown at Fig. 5C in the buffer described above for 20 min. DNA (20 nM) containing a 5Ј 32 P label on one strand and a thiol-modified cytosine on the other strand was added, and reactions were capped with methylmethanethiosulfonate at 1 min. After capping, nonreducing gel loading buffer (100 mM Tris-HCl, pH 6.8, 4% SDS, 0.2% bromphenol blue, and 20% glycerol) was added, and samples were directly loaded on 16% Tricine gels (Invitrogen). Gels were dried, and reaction products were quantitated as described above.
Integrase Binding to HIV DNA Using the Schiff-Base Assay. The Schiff-base assay was performed as described previously (Mazumder and Pommier, 1995) . In brief, 300 nM recombinant IN was incubated with inhibitors (at the indicated concentration) for 15 min at 37°C. Subsequently, 20 nM 5Ј end-labeled substrate containing the abasic oligonucleotide ( Fig. 6A ) was added for 10 min at room temperature in reaction buffer described above for integrase catalytic assays. A freshly prepared solution of sodium borohydride (0.1 M final concentration) was added for 5 min. An equal volume (10 l) of 2ϫ SDS-polyacrylamide gel electrophoresis buffer (Invitrogen) was added in each reaction. Reaction products were heated at 95°C for 1 min before analysis by electrophoresis in 12 to 20% polyacrylamide gels (Invitrogen). Gels were dried, and reaction products were quantitated using the same method as described above.
Fluorimetric HIV-1 Protease Assay. The fluorescent HIV-1 protease substrate [RE-(EDANS)-SQNYPIVQK-(DABCYL)-R] was obtained from Molecular Probes (Eugene, OR). Substrate and buffer were prewarmed at 37°C for at least 20 min before use. The protease (25 nM final concentration) was incubated in the manufacturer's recommended assay buffer (100 mM sodium acetate, 1 M NaCl, 1 mM EDTA, 1 mM dithiothreitol, 10% DMSO and 1 mg/ml bovine serum albumin, pH 4.7) at 37°C in the presence of 1 to 25 M NSC 18806 for 10 min and then added to the warmed substrate solution (40 M) containing the different treatments to initiate the reaction. Acetyl pepstatin (Sigma-Aldrich, St. Louis, MO) at 20 nM was used a positive HIV-1 protease inhibitor control. The total assay volume was 100 l. Fluorescence was monitored for 30 min in a fluorescence microplate reader (FMAX; Molecular Devices, Sunnyvale, CA) with 355-nm excitation and 460-nm emission filters, and the rate of reactions was compared for the different conditions.
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Inhibition of HIV-Induced Cytopathic Effect in Cell Culture. The MT-2 cells were grown in RPMI 1640 medium with GlutaMAX, supplemented with 10% (v/v) heat-inactivated fetal bovine serum (both from Invitrogen). The cells were maintained at 37°C in a humidified atmosphere of 5% CO 2 in air. Every 4 to 5 days, cells were spun down and seeded at 2 ϫ 10 5 cells/ml in new cell culture flasks. HIV (HTLV-IIIB isolate) was obtained from Advanced Biotechnology Incorporated (Columbia, MD). The virus stock (3.2 ϫ 10 4 50% cell culture infective dose per milliliter as determined for MT-2 cells) was stored at Ϫ70°C until used. Stock solutions of compounds were diluted using medium directly into 96-well assay plate (Corning, Corning, NY).
MT-2 cells (5 ϫ 10 5 cells/ml) were pretreated for 2 h with test compounds at various concentrations as indicated in Fig. 7 . Cells were then infected with 100 50% cell culture infective dose or mockinfected. The cell cultures were incubated at 37°C in a humidified atmosphere of 5% CO 2 in air. Four days after infection, the viability of mock-and HIV-infected cells was examined spectrophotometrically by the CellTiter 96 nonradioactive cell proliferation assay (Promega, Madison, WI) and also confirmed microscopically in a hemacytometer by the trypan blue exclusion method. The percentage of cell viability in drug-treated uninfected and infected cells was determined based on the viability of the uninfected control drug-treated cells. The concentration of drug required to inhibit approximately 50% of the HIV-1-induced cytotoxicity was calculated from the plot of compound concentration versus the percentage of viable cells.
Results

The 7-Hydroxy Group Is Essential for Inhibition of HIV-1 Integrase by Tropolone Derivatives.
The tropolone derivatives tested in this study are shown in Table 1 .
Compounds were first screened for inhibition of HIV-1 integrase in the presence of Mn 2ϩ as a cofactor using DNA substrates mimicking the U5 LTR viral DNA end (Fig. 1A) . The derivative containing only the minimal tropolone core structure (NSC 89303; Table 1 ) showed only marginal inhibition (IC 50 Ͼ 333 M). Addition of an isopropyl group at positions 5 (NSC 43338), 4 (NSC 18804), and 3 (NSC 18805), and of a 3-methyl-2-butenyl group at position 5 along with an isopropyl at the 4 position (NSC 43339) failed to increase potency. However, addition of a hydroxy group at position 7 (␣-hydroxytropolone) resulted in inhibitory activity against HIV-1 integrase (NSC 18806 and NSC 310618) . NSC 18806 was the most inhibitory against integrase in strand transfer reaction (IC 50 ϭ 4.8 Ϯ 2.5 M) compared with NSC 310618 (IC 50 ϭ 11.7 Ϯ 5.2 M) ( Table 1) .
The Tropolone NSC 18806 Inhibits Preferentially Strand Transfer in the Presence of Magnesium. For detailed characterization of NSC 18806, we compared its effect on the three reactions catalyzed by HIV integrase. 3Ј Processing, strand transfer, and disintegration can be independently measured in biochemical assays using specific oligonucleotides (Figs. 1A, 2A , and 3A) (Marchand et al., 2001 , is required for integrase activity in vitro (Engelman and Craigie, 1995 (Grobler et al., 2002; Neamati et al., 2002; Marchand et al., 2003) , all assays were performed in the presence of either Mg 2ϩ or Mn 2ϩ . . Therefore, NSC 18806 shows some selectivity for ST.
Because ST follows 3Ј-P in the reaction using the 21-bp DNA substrate shown in Fig. 1 , independent measurement of ST was performed with a preprocessed substrate (Fig. 2A) . This assay segregates the action of a compound against ST from a decrease of the integrase activity related to the 3Ј-P inhibition in the overall integration. Results from this assay show similar ST inhibition and comparable IC 50 values for ST as were observed for overall integration (Figs. 1B, 2B , and 4; Table 1 ) with exception for NSC 310618.
Disintegration was suggested as a reverse reaction of ST (Chow et al., 1992) (Fig. 3A) . Figure 3B shows the inability of NSC 18806 to inhibit disintegration in the presence of Mg 2ϩ . Disintegration was only inhibited in the presence of Mn 2ϩ at high drug concentration. These results indicate that NSC 18806 is a more potent inhibitor of ST compared with disintegration ( Fig. 4 ; Table 1 ).
NSC 18806 Affects the HIV-1 Integrase Catalytic Site without Inhibiting Overall DNA Binding. For determination of the possible binding site of NSC 18806 within the integrase catalytic site, we evaluated the ability of NSC 18806 to inhibit a cross-linking reaction between the cytosine in the 5Ј-AC dinucleotides overhang of the viral DNA and integrase glutamine 148 (Fig. 5A) . A Q148C mutant form of HIV-1 integrase allows specific covalent interaction with a thiol-modified cytosine in the 5Ј-AC dinucleotide overhang without nonspecific interference of other integrase cysteine residues (Johnson et al., 2006) .
The results of this assay show metal-dependent inhibition of integrase-DNA disulfide-cross-linking by NSC 18806 (Fig.  5B) . The importance of the ␣-hydroxy group in this inhibition is illustrated by the lack of inhibition observed for NSC 18804 (structural analog of NSC 18806 lacking the ␣-hydroxy group) (Fig. 5B) . For quantitative analysis of dose-dependent inhibition of integrase-DNA disulfide-cross-linking by NSC 18806, we performed the assay using 5Ј 32 P-labeled DNA substrate (Johnson et al., 2006) . The sensitivity of this method allows reactions to be performed with the same ratio of integrase-DNA as in the assays measuring ST. Inhibition of integrase cross-linking by NSC 18806 was observed at concentrations similar to those required to inhibit ST (Fig.  5C ). Integrase-DNA complexes were represented by several bands (Fig. 5C, left) , with the lowest corresponding to integrase-monomer-DNA (confirmed by Western blot experiments; data not shown). The slower migrating bands correspond to integrase-multimer-DNA complexes (dimer, trimer, tetramer, and so on) because of nondenaturing electrophoresis conditions. The IC 50 for cross-linking inhibition (32 M) is comparable with the IC 50 for the ST inhibition in the presence of Mg 2ϩ (21.6 Ϯ 3.4 M; Table 1 ). To determine whether cross-linking inhibition could be because of inhibition of overall binding of HIV-1 integrase to the viral DNA end, we investigated the effect of tropolone derivatives using a Schiff-base assay (Mazumder and Pommier, 1995) measuring cross-linking between integrase and a 
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DNA substrate mimicking the viral U5 LTR end and containing an abasic site corresponding to the adenine in the conserved CA-dinucleotide (Fig. 6A) . Tropolone derivatives did not block the Schiff base IN-DNA interaction even at 1 mM concentration (Fig. 6B) , indicating specific inhibition of disulfide cross-linking by NSC 18806.
NSC 18806 Exhibits Moderate Cytoprotective Activity against HIV-1 in Cell-Based Assay. The tropolone compounds shown in Table 1 were tested in an HIV infectivity assay (Pauwels et al., 1988) . All compounds were inactive in this assay except for the NSC 18806, which showed moderate protection of infected cells from HIV-induced cytopathic effect with an estimated IC 50 of approximately 12 M (Fig. 7) . The IC 50 could only be estimated because of the presence of toxicity at concentrations at and above 12 M. Note, that the cytoprotective concentration for this compound is comparable with the IC 50 for integrase inhibition in vitro in the presence of Mg 2ϩ .
Discussion
Tropolone derivatives have a range of antimicrobial activities. They are antifungal (Baya et al., 2001) , antibacterial (Morita et al., 2004) , and insecticidal (Morita et al., 2003) . They also exhibit antioxidant properties (Doulias et al., 2005) . Specific inhibition of the RNaseH domain of HIV-1 reverse transcriptase by 7-hydroxytropolone derivatives (␣-hydroxytropolones) have been reported (Budihas et al., 2005) . These various biological activities of tropolone derivatives have been linked with their ability to chelate metals (Matsumura et al., 2001; Budihas et al., 2005; Doulias et al., 2005) . Tropolone interacts with Mg 2ϩ by forming of a 1:1 complex (Andreu and Timasheff, 1982) . The current study suggests that ␣-hydroxytropolones may also inhibit HIV-1 integrase by chelation of one or two Mg 2ϩ or Mn 2ϩ in the enzyme active site (Fig. 8) . According to the two cross-linking assays, ␣-hydroxytropolones interfere with the protruding 5Ј end of the LTR and the integrase amino group glutamine 148 in the integrase flexible loop (inhibition of disulfide cross-linking) without affecting the overall binding of integrase to the viral DNA end (no inhibition of Schiff-base cross-linking). It has been suggested that the interaction between the cytosine in the 5Ј overhang of the viral DNA and the Q148 occurs after a conformational change of the integrase-viral (donor) DNA complex, which is necessary for triggering ST (Johnson et al., 2006) . Thus, the cross-linking results coupled with the ability of ␣-hydroxytropolones to preferentially inhibit ST (full-length or preprocessed substrate) compared with 3Ј-P in the presence of Mg 2ϩ suggest preferential binding of the ␣-hydroxytropolones to the integrase-DNA complex after 3Ј-P.
The lack of inhibition of the disintegration reaction by ␣-hydroxytropolones in the presence of Mg 2ϩ compared with effective inhibition of the ST reaction is noticeable because disintegration corresponds to the reverse reaction of strand transfer (Chow et al., 1992) . The same selectivity for strand transfer versus disintegration was shown for the diketo acid derivative L-731,988 and led to the interpretation that diketo acids bind to the target DNA site . Competition with target (acceptor) DNA could explain why NSC 18806 has a lower affinity for binding to the integrase catalytic active site if this site is already occupied by the donor and acceptor DNA, Fig. 1A ): 3Ј-P, triangles; and ST, circles. B, strand transfer assays with the preprocessed DNA substrate (see Fig. 2A ). C, disintegration assays with the Y-substrate (see Fig. 3A ). Data represent mean Ϯ S.D. for at least three independent experiments. which would be the case for the disintegration substrate. Hence, ␣-hydroxytropolones might act as interfacial inhibitors (Pommier and Cherfils, 2005; for HIV-1 integrase-divalent metal-DNA complexes and block the binding of the acceptor (genomic) DNA.
We find that ␣-hydroxytropolones are more potent but less selective for ST in the presence of Mn 2ϩ than in the presence of Mg 2ϩ . Such metal-dependent inhibition might be because of a different folding of the integrase active site in the presence of Mg 2ϩ or Mn 2ϩ . Mn 2ϩ is geometrically wider than Mg 2ϩ (Huang et al., 1997; Bock et al., 1999) ; therefore, the catalytic site of integrase could be more "open" in the presence of Mn 2ϩ , which might allow the ␣-hydroxytropolones to enter various conformations of this site. The lack of integrase inhibition using preprocessed substrate by NSC 310618 in the presence of Mg 2ϩ might be indicative of different integrase configurations when ST proceeds from a precleaved (preprocessed) substrate versus a blunt end substrate.
NSC 18806 shows weak cytoprotective activity on HIVinfected cells, which seems limited by the cytotoxicity of the drug. The cytoprotection against virus could be because of 
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at ASPET Journals on November 7, 2017 molpharm.aspetjournals.org drug action against other steps beside HIV replication. However, we can exclude HIV protease as NSC 18806 failed to inhibit HIV-1 protease at concentration up to 25 M in a standard fluorescent-based HIV-1 protease assay (data not shown). It has been reported that the ␣-hydroxytropolones inhibit the RNaseH domain of HIV-1 reverse transcriptase (Budihas et al., 2005) . The topological similarity between the catalytic domain of HIV integrase and the HIV reverse transcriptase RNaseH domain could explain a common mechanism of metal chelation in the enzyme catalytic site(s) (Dyda et al., 1994; Yang and Steitz, 1995) . While our study was under review, it was reported that 3,7-dihydroxytropolones also inhibit HIV integrase but at the same time block preferentially the polymerase activity of HIV reverse transcriptase over its RNaseH activity (Didierjean et al., 2005) . The synthesis of more active compounds based on the 7-hydroxytropolone core is needed for developing therapeutically relevant compounds and for investigating which step of the retroviral infection is inhibited by ␣-hydroxytropolones.
